Biosyent Stock Price Prediction
| RX Stock | CAD 11.26 0.08 0.71% |
Oversold Vs Overbought
46
Oversold | Overbought |
Quarterly Earnings Growth 0.107 | EPS Estimate Next Quarter 0.14 | Wall Street Target Price 11.75 | EPS Estimate Current Quarter 0.1 | Quarterly Revenue Growth 0.123 |
Using Biosyent hype-based prediction, you can estimate the value of Biosyent from the perspective of Biosyent response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Biosyent to buy its stock at a price that has no basis in reality. In that case, they are not buying Biosyent because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Biosyent after-hype prediction price | CAD 11.26 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Biosyent |
Biosyent After-Hype Price Prediction Density Analysis
As far as predicting the price of Biosyent at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Biosyent or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Biosyent, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Biosyent Estimiated After-Hype Price Volatility
In the context of predicting Biosyent's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Biosyent's historical news coverage. Biosyent's after-hype downside and upside margins for the prediction period are 9.31 and 13.21, respectively. We have considered Biosyent's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Biosyent is not too volatile at this time. Analysis and calculation of next after-hype price of Biosyent is based on 3 months time horizon.
Biosyent Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Biosyent is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Biosyent backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Biosyent, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.08 | 1.95 | 0.00 | 0.02 | 3 Events / Month | 0 Events / Month | In about 3 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
11.26 | 11.26 | 0.00 |
|
Biosyent Hype Timeline
Biosyent is at this time traded for 11.26on TSX Venture Exchange of Canada. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.02. Biosyent is estimated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is estimated to be very small, whereas the daily expected return is at this time at 0.08%. %. The volatility of related hype on Biosyent is about 672.41%, with the expected price after the next announcement by competition of 11.28. About 34.0% of the company outstanding shares are owned by corporate insiders. The book value of Biosyent was at this time reported as 2.96. The company last dividend was issued on the 4th of September 2024. Given the investment horizon of 90 days the next estimated press release will be in about 3 days. Check out Biosyent Basic Forecasting Models to cross-verify your projections.Biosyent Related Hype Analysis
Having access to credible news sources related to Biosyent's direct competition is more important than ever and may enhance your ability to predict Biosyent's future price movements. Getting to know how Biosyent's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Biosyent may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| CPH | Cipher Pharmaceuticals | 0.82 | 4 per month | 0.00 | (0.07) | 6.07 | (6.81) | 20.09 | |
| COV | Covalon Technologies | 0.00 | 2 per month | 2.32 | 0.04 | 6.30 | (3.30) | 15.59 | |
| GUD | Knight Therapeutics | 0.05 | 3 per month | 0.00 | (0.09) | 3.47 | (1.83) | 17.56 |
Biosyent Additional Predictive Modules
Most predictive techniques to examine Biosyent price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Biosyent using various technical indicators. When you analyze Biosyent charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Biosyent Predictive Indicators
The successful prediction of Biosyent stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Biosyent, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Biosyent based on analysis of Biosyent hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Biosyent's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Biosyent's related companies. | 2023 | 2024 (projected) | Dividend Yield | 0.0179 | 0.00944 | Price To Sales Ratio | 3.39 | 2.93 |
Story Coverage note for Biosyent
The number of cover stories for Biosyent depends on current market conditions and Biosyent's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Biosyent is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Biosyent's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Biosyent Short Properties
Biosyent's future price predictability will typically decrease when Biosyent's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Biosyent often depends not only on the future outlook of the potential Biosyent's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Biosyent's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 12.2 M | |
| Cash And Short Term Investments | 26.2 M |
Additional Tools for Biosyent Stock Analysis
When running Biosyent's price analysis, check to measure Biosyent's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biosyent is operating at the current time. Most of Biosyent's value examination focuses on studying past and present price action to predict the probability of Biosyent's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biosyent's price. Additionally, you may evaluate how the addition of Biosyent to your portfolios can decrease your overall portfolio volatility.